Tetrandrine induces autophagy and differentiation by activating ROS and Notch1 signaling in leukemia cells

Oncotarget
Ting LiuWenhua Li

Abstract

All-trans retinoic acid (ATRA) is a differentiating agent for the treatment of acute promyelocytic leukemia (APL). However, the therapeutic efficacy of ATRA has limitations. Tetrandrine is a traditional Chinese medicinal herb extract with antitumor effects. In this study, we investigated the effects of tetrandrine on human PML-RARα-positive acute promyelocytic leukemia cells. Tetrandrine inhibited tumors in vivo. It induced autophagy and differentiation by triggering ROS generation and activating Notch1 signaling. Tetrandrine induced autophagy and differentiation in M5 type patient primary leukemia cells. The in vivo results indicated that low concentrations of tetrandrine inhibited leukemia cells proliferation and induced autophagy and then facilitated their differentiation, by activating ROS and Notch1 signaling. We suggest that tetrandrine is a potential agent for the treatment of APL by inducing differentiation of leukemia cells.

References

Jul 1, 1987·Journal of Natural Products·P L Schiff
Dec 2, 2000·Science·D J Klionsky, S D Emr
Jan 2, 2003·Molecular and Cellular Biology·Andrew P WengJon C Aster
Oct 28, 2004·Gastroenterology·F Xavier BoschRamon Cléries
Nov 19, 2004·Nature·Charles Sawyers
Feb 8, 2005·Cancer Letters·Raffaella ChiaramontePaola Comi
Apr 1, 2006·FEBS Letters·Anne Wilson, Freddy Radtke
Nov 28, 2006·Lancet·Elihu Estey, Hartmut Döhner
Apr 13, 2007·Nature·Beth Levine
Sep 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Teresa Palomero, Adolfo Ferrando
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eileen White, Robert S DiPaola
Oct 23, 2010·Nature Reviews. Cancer·Hugues de Thé, Zhu Chen
Dec 4, 2010·International Journal of Cancer. Journal International Du Cancer·Chaoyang LiuWenhua Li
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan BurnettBob Löwenberg
Dec 25, 2012·Biochemical and Biophysical Research Communications·Zhao-Wen YanYing Huang
Jan 19, 2013·Autophagy·Kara L ConwayRamnik J Xavier
Apr 9, 2013·Acta Pharmacologica Sinica·Xin LiJin-ku Bao
Jul 12, 2013·The New England Journal of Medicine·Francesco Lo-CocoUNKNOWN Study Alliance Leukemia
Oct 23, 2013·Autophagy·Maria Lyngaas Torgersen, Anne Simonsen
Feb 14, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Alberto BavelloniWilliam L Blalock
Apr 4, 2014·Experimental Cell Research·Nina OrfaliNigel P Mongan
Jul 9, 2014·British Journal of Cancer·M ValenzuelaP Buc Calderon
Aug 12, 2014·Blood Reviews·Justin M Watts, Martin S Tallman
Oct 17, 2014·Journal of Pharmacological Sciences·Takeaki Nitto, Kohei Sawaki

❮ Previous
Next ❯

Citations

Mar 22, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Betty Yuen Kwan LawVincent Kam Wai Wong
Jun 29, 2017·International Journal of Oncology·Mingjiang YaoNorio Takagi
Sep 29, 2018·Cancers·Mouna SdiriBurton B Yang
May 23, 2017·Oncology Letters·Wei QiuYe Tian
Feb 6, 2017·Journal of Cellular and Molecular Medicine·Chuyue ZhangZhuo Yang
Dec 31, 2019·Seminars in Cancer Biology·Thomas Efferth, Franz Oesch
Nov 14, 2017·Journal of Natural Products·Da-Hong LiZhan-Lin Li

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
xenografts
MDA
Flow cytometry
confocal microscopy
ubiquitination
Protein Assay
fluorescence
PCR

Software Mentioned

7500 system SDS
FlowJo Star
FlowJo

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms